>>That increases the FCF and value of those companies a lot. Money losing companies do not get that bump.
But still increases their NPV (assuming people think rates will stay low).
If your theory was correct, there should be a big discrepancy between the profitable biotechs with high tax rates (should be strong) and those with low rates and the unprofitable ones.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.